Cardiovascular Effects of the Novel Potassium Channel Opener Bimakalim in Conscious Pigs After Myocardial Infarction: a Comparative Study with Nicorandil

Overview

Journal Cardiovasc Drugs Ther

Specialties Cardiology & Vascular Diseases
Pharmacology

Date 1992 Aug 1

PMID 1387797

Authors

L J van Woerkens

N R Baas

W J van der Giessen

P D Verdouw

Affiliations

Soon will be listed here.

Abstract

The benzopyran-derivative bimakalim is an ATP-dependent potassium channel activator that has been shown to be a potent arterial vasodilator in anesthetized pigs. In the present study we evaluated the cardiovascular profile of bimakalim in normal conscious animals and conscious animals with chronic left ventricular dysfunction and compared the results to those obtained with nicorandil. In normal conscious pigs, bimakalim (37.5-300 ng/kg/min, n = 6) and nicorandil (10-80 micrograms/kg/min, n = 8) increased cardiac output from 2.7 +/- 0.1 l/min to 3.8 +/- 0.2 l/min and from 2.7 +/- 0.1 l/min to 3.9 +/- 0.3 l/min (both p less than .05) due to increases in heart rate (up to 62 +/- 14% and 74 +/- 9%, respectively, both p less than .05). The mean arterial blood pressure decreased gradually from 104 +/- 4 mmHg to 91 +/- 5 mmHg with bimakalim and from 98 +/- 3 mmHg to 84 +/- 5 mmHg with nicorandil (both p less than .05), due to similar decreases in systemic vascular resistance. LVdP/dtmax also increased with both drugs (up to 48 +/- 11% and 69 +/- 7%, respectively, p less than .05), but left ventricular end-diastolic pressure remained unchanged with bimakalim, while it gradually decreased from 9 +/- 1 mmHg to 5 +/- 1 mmHg (p less than .05) with nicorandil. In pigs with a 3- to 4-week-old myocardial infarction, the vasodilator responses to bimakalim (n = 8) and nicorandil (n = 9) were not affected, but the increases in heart rate and LVdP/dtmax were attenuated compared to the effects in the normal animals.(ABSTRACT TRUNCATED AT 250 WORDS)

References

van der Giessen W, van Woerkens L, Duncker D, Roelandt J, Verdouw P . Acute hemodynamic effects of nisoldipine and pimobendan in conscious pigs with chronic heart failure. J Cardiovasc Pharmacol. 1989; 14(4):653-8. DOI: 10.1097/00005344-198910000-00019. View

Nakaya H, Schwartz A, Millard R . Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared. Circ Res. 1983; 52(3):302-11. DOI: 10.1161/01.res.52.3.302. View

Scheffer M, Verdouw P . Decreased incidence of ventricular fibrillation after an acute coronary artery ligation in exercised pigs. Basic Res Cardiol. 1983; 78(3):298-309. DOI: 10.1007/BF01907439. View

Duncker D, Saxena P, Verdouw P . Systemic haemodynamics of dihydropyridine derivatives in conscious pigs with or without propranolol. Eur J Pharmacol. 1988; 156(3):401-9. DOI: 10.1016/0014-2999(88)90286-5. View

Silke B, Verma S, Midtbo K, Muller P, Frais M, Reynolds G . A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart disease. Int J Cardiol. 1986; 13(2):231-41. DOI: 10.1016/0167-5273(86)90147-6. View

Richer C, Mulder P, Doussau M, Gautier P, Giudicelli J . Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR. Br J Pharmacol. 1990; 100(3):557-63. PMC: 1917799. DOI: 10.1111/j.1476-5381.1990.tb15846.x. View

Buckingham R, Clapham J, Hamilton T, Longman S, Norton J, Poyser R . BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol. 1986; 8(4):798-804. DOI: 10.1097/00005344-198709010-00022. View

van Woerkens L, van der Giessen W, Verdouw P . The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion. Cardiovasc Drugs Ther. 1992; 6(1):59-65. DOI: 10.1007/BF00050918. View

Sassen L, Duncker D, Gho B, Diekmann H, Verdouw P . Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs. Br J Pharmacol. 1990; 101(3):605-14. PMC: 1917749. DOI: 10.1111/j.1476-5381.1990.tb14128.x. View

10.

Verdouw P, Sassen L, Duncker D, Schmeets I, Rensen R, Saxena P . Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(3):352-8. DOI: 10.1007/BF00172690. View

11.

Warltier D, Zyvoloski M, Gross G, Brooks H . Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. J Pharmacol Exp Ther. 1984; 230(2):367-75. View

12.

Gotanda K, Satoh K, Taira N . Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?. J Cardiovasc Pharmacol. 1988; 12(2):239-46. DOI: 10.1097/00005344-198808000-00015. View

13.

van Woerkens L, Schotman S, van der Giessen W, Verdouw P . Cardiovascular effects of elgodipine in conscious pigs with a normal coronary circulation and in conscious pigs with a healed myocardial infarction. J Cardiovasc Pharmacol. 1991; 17(6):976-82. DOI: 10.1097/00005344-199106000-00018. View

14.

Cook N . The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988; 9(1):21-8. DOI: 10.1016/0165-6147(88)90238-6. View

15.

de Peyer J, Lues I, GERICKE R, Hausler G . Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments. Pflugers Arch. 1989; 414 Suppl 1:S191. DOI: 10.1007/BF00582301. View

16.

Findlay I, Deroubaix E, Guiraudou P, CORABOEUF E . Effects of activation of ATP-sensitive K+ channels in mammalian ventricular myocytes. Am J Physiol. 1989; 257(5 Pt 2):H1551-9. DOI: 10.1152/ajpheart.1989.257.5.H1551. View

17.

Taira N . Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989; 63(21):18J-24J. DOI: 10.1016/0002-9149(89)90200-2. View

18.

van Woerkens L, van der Giessen W, Verdouw P . Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction. Br J Pharmacol. 1991; 104(1):7-14. PMC: 1908261. DOI: 10.1111/j.1476-5381.1991.tb12376.x. View

19.

Sassen L, Soei L, Koning M, Verdouw P . The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs. Br J Pharmacol. 1990; 99(2):355-63. PMC: 1917371. DOI: 10.1111/j.1476-5381.1990.tb14708.x. View

20.

Hamilton T, Weir S, Weston A . Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986; 88(1):103-11. PMC: 1917115. DOI: 10.1111/j.1476-5381.1986.tb09476.x. View